Dakovir-C

Daclatasvir INN 60mg tablet
Tablet

Dakovir-C (daclatasvir) is an inhibitor of HCV nonstructural protein 5A (NS5A). Daclatasvir is an inhibitor of NS5A, a nonstructural protein encoded by HCV. Daclatasvir binds to the N-terminus of NS5A and inhibits both viral RNA replication and virion assembly. It is indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3 infection.

It is EASL (Europen Association for the Study of Liver), APASL (Asia Pacific Association for the Study of Liver) recommended Pangenotypic treatment option for Hepatitis C with other Direct Acting Antivirals.

Dakovir-C is a PANGENOTYPIC, EFFECTIVE AND ECONOMIC treatment for HCV and numerous benefits:
Company

  • Highly effective in all genotype of HCV with other DAAs
  • Most economic option to treat hepatitis C
  • Shorter treatment period than other antiviral therapy
  • Effective in HCV patient with cirrhosis


Dakovir-C Prescribing Information

Located in: Anti-infectives